NL-OMON49463已完成不适用
IVDR Performance Evaluation TROPT Sensitive and Intermediate Precision cobas h 232 - Performance evaluation TROPT Sensitive en cobas h 232
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •New-onset typical chest pain and other symptoms suggestive of acute coronary
排除标准
- •Age <21 years
- •Self-declared pregnancy
- •Breast-feeding women
- •Relative or spouse of the investigator
研究者
相似试验
已完成
不适用
Assessing effectiveness of an e-learning tool to aid junior doctor management of febrile childreInjuries and Emergencies, Paediatrics, Critical CareISRCTN94772165niversity of Leicester100
已完成
不适用
An exploratory study to assess the RSV titer in healthy volunteers as guidance for the main studycommon coldNL-OMON44515Intravacc100
已完成
3 期
Evaluation of the Performance of a new test for the diagnosis of high risk tuberculosis.CTRI/2020/06/026021bioMerieux37
尚未招募
3 期
IVD1: Clinical Performance Study Plan For The Use of Myriad MyChoice® For Patient Enrolment Into the AZD5305 (Saruparib) vs Placebo in Participants with Metastatic Castration-Sensitive Prostate Cancer Receiving Physician*s Choice New Hormonal Agents;IVD2: Clinical Performance Study Plan for F1LCDx Used in Clinical Trial EvoPAR-Prostate01 ;Main: A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician*s Choice New Hormonal Agents in PatieMetastatic Castration-Sensitive Prostate Cancer10038597Prostate cancerNL-OMON56674Astra Zeneca19
尚未招募
不适用
An interventional, prospective IVD device study for the testing of DNA extracted from tumor tissue biopsy samples in a first line setting from patients diagnosed with metastatic Colorectal Cancer (mCRC) to determine the KRAS G12C mutation status as part of the inclusion criteria into the Amgen Phase III clinical trial (Protocol No 20210081) to demonstrate clinical performance of the therascreen® KRAS RGQ PCR Kit.metastatic Colorectal Cancer10002112NL-OMON56931QIAGEN Manchester Ltd16